Velocity pAVF System
Vascular access for hemodialysis
Key Facts
About Venova Medical
Venova Medical is a clinical-stage medical device company targeting the critical unmet need for reliable, functional vascular access in end-stage renal disease patients requiring hemodialysis. Its core technology, the Velocity pAVF System, is a minimally invasive device designed to create arteriovenous fistulas percutaneously, aiming for faster maturation and fewer follow-up interventions compared to surgical methods. The company has generated promising early clinical data from its VENOS-1 and VENOS-2 studies and has initiated a pivotal IDE study (VENOS-3) in the United States. Venova is positioned to address a large market burdened by high catheter use, poor patient outcomes, and significant healthcare costs associated with current vascular access options.
View full company profileTherapeutic Areas
Other Vascular access for hemodialysis Drugs
| Drug | Company | Phase |
|---|---|---|
| Cerulean Hemodialysis Catheter™ | Cerulean Scientific | Preclinical |
| Needleless Vascular Access System | Kuleana Technology | Pre-clinical |
| aXess | Xeltis | Pivotal/Pre-market |